Medicare coverage for GLP-1 medications has been evolving rapidly. Medicare Part D covers GLP-1 medications prescribed for type 2 diabetes (Ozempic, Mounjaro). The landmark expansion of Medicare to cover anti-obesity medications has been a major development in 2025-2026, with Wegovy and Zepbound becoming available under certain Part D plans.

Medication Coverage

Medication	Status	Notes
Ozempic (semaglutide)	Covered	Covered for type 2 diabetes under Medicare Part D. Subject to plan-specific formulary placement and cost-sharing. Not covered for off-label weight loss.
Wegovy (semaglutide)	Varies	FDA-approved for weight management. Medicare coverage expanding through legislative and CMS policy changes. Check your specific Part D plan for current status.
Mounjaro (tirzepatide)	Covered	Covered for type 2 diabetes. Strong formulary position across most Part D plans.
Zepbound (tirzepatide)	Varies	FDA-approved for weight management. Coverage under Medicare is expanding. Check your specific Part D plan.

Cost Estimates

With Medicare

$35-$200/month (after deductible, varies by plan and coverage phase)

Without Insurance

$800-$1,400/month

Savings tip: The Inflation Reduction Act capped out-of-pocket Part D costs at $2,000/year starting in 2025. This significantly reduces the annual cost burden for expensive GLP-1 medications. Extra Help (Low Income Subsidy) can further reduce costs.

Medicare GLP-1 FAQ for Delaware

How many GLP-1 clinics accept Medicare in Delaware?

There are 8 GLP-1 clinics in Delaware that have reported accepting Medicare insurance. Out of 38 total clinics in the state, these providers can help you access GLP-1 medications with your Medicare plan.

Does Medicare cover GLP-1 medications in Delaware?

Medicare generally covers GLP-1 medications like Ozempic and Mounjaro for type 2 diabetes across all states including Delaware. Coverage for weight management medications (Wegovy, Zepbound) varies by plan. Contact Medicare directly or check your plan documents for specific coverage details.

How do I get prior authorization for GLP-1 medications with Medicare in Delaware?

Your prescribing doctor in Delaware submits a prior authorization request to Medicare with your diagnosis, BMI, and treatment history. Processing typically takes 2-10 business days. Ask your clinic to submit the request proactively to avoid delays.

What if Medicare denies my GLP-1 prescription in Delaware?

You have the right to appeal any denial. Ask your doctor to submit a peer-to-peer review or formal appeal with additional clinical documentation. Many initial denials are overturned on appeal. Delaware insurance regulations may provide additional appeal protections.